IRCCS Humanitas Research Hospital, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Front Immunol. 2024 Feb 14;15:1341390. doi: 10.3389/fimmu.2024.1341390. eCollection 2024.
The tumor microenvironment is composed of tumor cells, stromal cells and leukocytes, including innate and adaptive immune cells, and represents an ecological niche that regulates tumor development and progression. In general, inflammatory cells are considered to contribute to tumor progression through various mechanisms, including the formation of an immunosuppressive microenvironment. Macrophages and neutrophils are important components of the tumor microenvironment and can act as a double-edged sword, promoting or inhibiting the development of the tumor. Targeting of the immune system is emerging as an important therapeutic strategy for cancer patients. However, the efficacy of the various immunotherapies available is still limited. Given the crucial importance of the crosstalk between macrophages and neutrophils and other immune cells in the formation of the anti-tumor immune response, targeting these interactions may represent a promising therapeutic approach against cancer. Here we will review the current knowledge of the role played by macrophages and neutrophils in cancer, focusing on their interaction with other immune cells.
肿瘤微环境由肿瘤细胞、基质细胞和白细胞组成,包括先天和适应性免疫细胞,代表了调节肿瘤发生和进展的生态位。一般来说,炎症细胞被认为通过多种机制促进肿瘤进展,包括形成免疫抑制微环境。巨噬细胞和中性粒细胞是肿瘤微环境的重要组成部分,它们可以充当双刃剑,促进或抑制肿瘤的发展。靶向免疫系统已成为癌症患者的重要治疗策略。然而,现有的各种免疫疗法的疗效仍然有限。鉴于巨噬细胞和中性粒细胞与其他免疫细胞之间的相互作用在抗肿瘤免疫反应中的重要性,靶向这些相互作用可能是一种有前途的抗癌治疗方法。在这里,我们将回顾巨噬细胞和中性粒细胞在癌症中的作用的现有知识,重点关注它们与其他免疫细胞的相互作用。